Tag: opioid
High-frequency SCS drives impactful outcomes for non-surgical refractory back pain patients
Following the recent introduction of key data supporting the use of high-frequency spinal cord stimulation (SCS) in the treatment of non-surgical refractory back pain...
New study shows improvement in opioid withdrawal symptoms through non-invasive neuromodulation
A late-breaking abstract presented at the North American Neuromodulation Society (NANS) 2021 virtual meeting (January 15–16) has shown that non-invasive neuromodulation may present a...
Decision-making in intrathecal drug delivery devices “life-threatening” amid COVID-19
Amid the COVID-19 pandemic, the need to prevent the spread of disease and manage critical hospital resources has never been more critical. In a...
Sheep model helps guide investigation of analgesia tolerance and reversal during...
Having been honoured with the Best Basic Science Abstract Award at the North American Neuromodulation Society’s (NANS) 2020 annual meeting (23–26 January, Las Vegas,...
Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...
Stimwave Technologies has announced that it has received US Food and Drug Administration (FDA) clearance for the WaveCrest Mobile iOS platform patient controllers for...
FDA approves new SynchroMed II myPTM Personal Therapy Manager that enables...
Medtronic has announced US Food and Drug Administration (FDA) approval of the new SynchroMed II myPTM Personal Therapy Manager for patients with chronic pain....
Medtronic launches the Control Workflow to help eliminate oral opioids and...
Medtronic has announced the US launch of the Control Workflow, an evidence-based approach for use with the SynchroMed II intrathecal drug delivery system ("Medtronic...
Spinal cord stimulation reduces or stabilises opioid use among chronic pain...
New research has found spinal cord stimulation therapy can reduce or stabilise the use of opioids in patients battling chronic pain. Researchers examined opioid...
